M&A Corner
ImmunoGen Inks Cancer ADC Partnership with ImmunoBiochem31 Jul 2023
ImmunoGen has formed a multi-target license and option partnership with ImmunoBiochem to develop antibody-drug conjugates (ADCs) against unique cancer targets.... Continue Reading
|
CareCloud, Google Cloud Partner to Bring Generative AI to Ambulatory Practices31 Jul 2023
Toronto-based startup Xandar Kardian has raised $10 million in funding for its XK300 Autonomous Health Monitoring Solution. The system is... Continue Reading
|
Hippocratic AI Raises $15M and More Digital Health Fundings31 Jul 2023
Hippocratic AI, a healthcare-focused generative AI company, secured an additional $15 million in funding for its seed round, reaching a... Continue Reading
|
Justera Health Completes the Acquisition of Juillet Wellness Centre31 Jul 2023
Justera Health Ltd. (CSE: VTAL) (OTCQB: SCRSF), formerly ScreenPro Security Inc., has successfully acquired Juillet Wellness Centre in Burnaby, British... Continue Reading
|
CareDx Acquires Organ Transplant Company MediGO31 Jul 2023
Precision medicine company CareDx has acquired MediGO, an organ transplant supply chain and logistics company, to enhance its digital health... Continue Reading
|
Practice Better Acquires Nutrition Planning Platform That Clean Life31 Jul 2023
Practice Better, an all-in-one practice management software platform for health and wellness professionals, has acquired That Clean Life, a nutrition... Continue Reading
|
Axxess Acquires Home Health EHR Complia Health31 Jul 2023
Axxess, a home healthcare technology provider, has acquired Complia Health, a leading EMR solutions provider for home care, home health,... Continue Reading
|
GreenLight Announces Completion of Merger with Fall Line Endurance Fund31 Jul 2023
GreenLight Biosciences Holdings (NASDAQ: GRNA) has completed its merger with SW MergerCo and SW ParentCo, with GreenLight surviving as a... Continue Reading
|
Infinity Pharmaceuticals Announces Termination of Merger Agreement with MEI Pharma31 Jul 2023
Infinity Pharmaceuticals Inc. has terminated its merger agreement with MEI Pharma Inc. after the latter failed to obtain stockholder approval... Continue Reading
|
Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company25 Jul 2023
Sosei Group Corporation has announced its acquisition of all shares of Idorsia Pharmaceuticals Japan Ltd and Idorsia Pharmaceuticals Korea Co.,... Continue Reading
|